| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HLF | Common Stock | +Buy | $498,300 | +61,725 | +11.39% | $8.07 | 603,707 | Feb 16, 2024 | Direct | F1 |
| transaction | HLF | Common Stock | +Grant/Award | $0 | +495,662 | +82.1% | $0.00 | 1,099,369 | Feb 16, 2024 | Direct | F2 |
| transaction | HLF | Common Stock | +Grant/Award | $0 | +84,839 | +7.72% | $0.00 | 1,184,208 | Feb 16, 2024 | Direct | F3 |
| transaction | HLF | Common Stock | -Tax liability | -$244,933 | -30,351 | -2.56% | $8.07 | 1,153,857 | Feb 16, 2024 | Direct | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HLF | Stock Appreciation Rights | +Grant/Award | $0 | +982,800 | $0.00 | 982,800 | Feb 16, 2024 | Common Stock | 982,800 | $8.07 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | This transaction represents multiple open market purchases. The range of prices for such transactions is $7.84 to $8.20. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a shareholder of the Issuer, full information regarding the number of shares purchased at each price. |
| F2 | Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These RSUs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Issuer's Board of Directors (the "Board"), subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the RSU vest prior to February 16, 2025. |
| F3 | Consists of RSUs fully vested at the time of grant. |
| F4 | Represents shares withheld to satisfy tax obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 16, 2024. |
| F5 | Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in two installments, 50% on February 16, 2025, and 50% on the earlier of January 3, 2026, or the date on which a new non-interim Chief Executive Officer has been appointed by the Board, subject to certain conditions of his service as CEO and/or member of the Board. Provided that, in no instance shall any portion of the SAR vest prior to February 16, 2025. |